Equivalence Trial of Melarsoprol and Nifurtimox Monotherapy and Combination Therapy for the Treatment of Second‐StageTrypanosoma brucei gambienseSleeping Sickness
The Journal of Infectious Diseases2007Vol. 195(3), pp. 322–329
Citations Over TimeTop 10% of 2007 papers
Sylvie Bisser, François‐Xavier N’Siesi, Veerle Lejon, Pierre‐Marie Preux, Simon Van Nieuwenhove, Constantin Miaka Mia Bilenge, Philippe Büscher
Abstract
A consecutive 10-day low-dose melarsoprol-nifurtimox combination is more effective than the standard melarsoprol regimen.
Related Papers
- → Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)(2012)436 cited
- → The trypanolytic factor of human serum(2006)192 cited
- → Human African Trypanosomiasis – A rare case report from India(2021)9 cited
- → 6-Arylpyrazine-2-carboxamides: A New Core for Trypanosoma brucei Inhibitors(2015)20 cited
- → Human African trypanosomiasis(2020)21 cited